Warren Rachel, Kenny Meghan, Bennett Teresa, Fitzpatrick-Lewis Donna, Ali Muhammad Usman, Sherifali Diana, Raina Parminder
Evidence Review and Synthesis Centre, and Offord Centre for Child Studies, McMaster University, Hamilton, Ont.
CMAJ Open. 2016 Jan 25;4(1):E20-7. doi: 10.9778/cmajo.20140121. eCollection 2016 Jan-Mar.
Existing guidelines on screening children less than 5 years of age for developmental delay vary. In this systematic review, we synthesized the literature on the effectiveness and harms of screening for developmental delay in asymptomatic children aged 1-4 years.
We searched MEDLINE, Embase and PsychINFO for relevant articles published to June 16, 2015. We identified studies that included children aged 1-4 years who were not at high risk of developmental delay, screened in a primary care setting. Randomized trials and controlled cohort studies were considered for benefits (cognitive, academic and functional outcomes); no restrictions on study design were imposed for the review of harms.
Two studies were included. One used the Ages and Stages Questionnaire II for screening and reported significantly more referrals to early intervention in the intervention groups than in the control group (relative risk [RR] 1.95, 95% confidence interval [CI] 1.49-2.54, in the intervention group with office support and RR 1.71, 95% CI 1.30-2.25, in the intervention group without office support). The time to referral was 70% shorter in the intervention group with office support (rate ratio 0.30, 95% CI 0.19-0.48) and 64% shorter in the intervention group without office support (rate ratio 0.36, 95% CI 0.23-0.59), compared with the control group. The other study used the VroegTijdige Onderkenning Ontwikkelingsstoornissen Language Screening instrument to screen children aged 15 months at enrolment for language delay. It reported no differences between groups in academic performance outcomes at age 8 years.
The evidence on screening for developmental delay in asymptomatic children aged 1-4 years is inconclusive. Further research with longer-term outcomes is needed to inform decisions about screening and screening intervals.
现有的关于筛查5岁以下儿童发育迟缓的指南各不相同。在这项系统评价中,我们综合了有关筛查1 - 4岁无症状儿童发育迟缓的有效性和危害的文献。
我们检索了MEDLINE、Embase和PsychINFO数据库,查找截至2015年6月16日发表的相关文章。我们纳入了在初级保健机构中对1 - 4岁且无发育迟缓高风险的儿童进行筛查的研究。随机试验和对照队列研究用于评估益处(认知、学业和功能结局);在审查危害时,对研究设计没有限制。
纳入了两项研究。一项研究使用《年龄与阶段问卷第二版》进行筛查,报告称干预组转介至早期干预的人数显著多于对照组(相对风险[RR]为1.95,95%置信区间[CI]为1.49 - 2.54,在有办公室支持的干预组中;RR为1.71,95% CI为1.30 - 2.25,在无办公室支持的干预组中)。与对照组相比,有办公室支持的干预组转介时间缩短了70%(率比为0.30,95% CI为0.19 - 0.48),无办公室支持的干预组转介时间缩短了64%(率比为0.36,95% CI为0.23 - 0.59)。另一项研究使用《早期发育障碍识别语言筛查工具》在儿童入学时对15个月大的儿童进行语言发育迟缓筛查。该研究报告称,两组在8岁时的学业成绩结局方面没有差异。
关于筛查1 - 4岁无症状儿童发育迟缓的证据尚无定论。需要进行更多具有长期结局的研究,为筛查决策和筛查间隔提供依据。